Get started
Author

Luciano Carestia

Observed names: Carestia, Luciano, L Carestia, L. Carestia
ORCID: 0000-0002-8296-5513
Observed ORCID: 0000-0002-8296-5513
OpenAlex ID: A5033159468
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
2015 · M. Schuler, J.C.-H. Yang, et al. · Annals of Oncology · 132
PDF
A pregnant patient with ALK‑positive non‑small cell lung cancer treated with alectinib: A case report and review of the literature
2022 · Fabian De Smedt, Frédérique Dessy, et al. · Oncology Letters · 13
Unplanned pregnancy in an HIV positive woman undergoing alectinib treatment for metastatic non-small-cell lung carcinoma
2022 · Séverine Carlier, Luciano Carestia, et al. · BMJ Case Reports · 5
[Management of small-cell bronchial cancer].
2000 · J L Pujol, X Quantin, et al. · PubMed · 2
A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non–small cell lung cancer
2022 · Anne Sibille, Frederique Bustin, et al. · Acta Oncologica · 1
PDF
Phase II study of induction chemotherapy with cisplatin (Cis) and gemcitabine (Gem) followed by concomitant Cis-Gem and thoracic radiation (RTX) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)
2009 · P. Driesen, L. Verbeke, et al. · Journal of Clinical Oncology
[Which chemotherapy for diffuse forms of small-cell cancers?].
1999 · J L Pujol, X Quantin, et al. · PubMed
Works count: 8
Citation count: 153
H-index: 3
I10-index: 2
Year
Topic
Type